Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Background: Antiviral drugs can cure more than 95 percent of people with hepatitis C, but the inaccessibility of quality affordable medicines and the lack of their uninterrupted supply poses a major challenge. Impurities in drugs have a significant impact on their quality and are one of the substantial causes of drug recalls, ultimately leading to the unavailability of the drug in the market. Hence, there is a need for a robust, quality risk management and quality by design-driven analytical method that can detect the antiviral drug, Daclatasvir dihydrochloride, in the presence of its probable impurities. Objective: This study aimed to develop a Quality by Design-driven stability- indicating liquid chromatography method for Daclatasvir dihydrochloride and the characterization of its putative degradants by LC-MS. Method: The fishbone diagram and quality risk assessment investigated twenty-four process parameters and concluded that three risk parameters,, flow rate, buffer pH, and stationary phase type, were the critical process parameters. The critical quality attributes viz. resolution between impurity 6 and DCV and impurity 2 & 3 (Rs#131;1.5), the shape of the peak of DCV which is decided by the Number of Theoretical Plates (NTP#131;5000), and the retention time of Daclatasvir (t14-23 mins) were optimized using a two-level three-factor full factorial design with five center points. Results: The optimized method is stability-indicating in its true sense as it can separate the sample with its degradants generated in basic (three), acidic (two), oxidative (HO: three, Azobisisobutyronitrile: one), photo (three), and dry heat (one) conditions. Degradants structures were elucidated, and degradation routes were established, using LC-MS and LC-MS/MS analyses. Conclusion: The drug is highly susceptible to acid, base hydrolysis, and oxidation degradation conditions and poses a significant risk to the analytical method to fail in system suitability criteria. Hence, a robust and flexible chromatographic method with the capacity for continuous improvement was developed and successfully validated within the criteria of design space.

Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129285465240408044841
2024-03-01
2025-05-09
Loading full text...

Full text loading...

/content/journals/cpa/10.2174/0115734129285465240408044841
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test